Renal microangiopathy induced by lenvatinib in hepatocellular carcinoma: a case report and literature review

• Main Authors: Cheng Xue (Author), Linlin Cui (Author), Jiaxin Chen (Author), Yang Liu (Author), Yufei Deng (Author), Wenyi Xu (Author), Zhiguo Mao (Author), Jun Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lenvatinib, a multi-target inhibitor of receptor tyrosine kinases, has been increasingly used in the treatment of advanced hepatocellular carcinoma (HCC). However, its association with renal adverse effects, including proteinuria and renal microvascular complications, was not fully understood in HCC...